The pledge for the fight against bird flu disease is announced at international conference in Egypt at Red Sea resort of Sharm el-Sheikh.

A single vaccine could be used to protect chickens, cats and humans against deadly flu pandemics, according to an article published in the November issue of the Journal of General Virology. The vaccine protects birds and mammals against different flu strains and can even be given to birds while they are still in their eggs, allowing the mass vaccination of wild birds.

Novavax, Inc. (Nasdaq: NVAX) today held an investor conference call to discuss results from the Phase I/IIa human clinical trial of Novavax’s H5N1 pandemic influenza VLP vaccine candidate at 11:00. This was a big news about the first favorable results in the search of bird flu vaccine for humans.

A new vaccine under development may provide protection against highly pathogenic bird flu and its evolving forms, according to researchers at Purdue University and the Centers for Disease Control and Prevention who discovered the new preventative drug and have tested it in mice.

Officials in China have given permission for a Chinese drug maker to begin commercial production of a human vaccine against bird flu after clinical trials showed it was effective. Scientists worldwide are trying to find a way to prevent transmission of the virus.

A home grown human bird flu vaccine has been given a go-ahead for commercial production by China, making it the second country in the world to have the technology and industrial capacity to do so.

Ukraine has almost completed clinical trials for a bird flu vaccine, the head of the Ukrainian State Veterinarian Department said Thursday. Since 2003, when bird flu first hit countries in Asia, international experts feared the virus could mutate into a form that spread easily among people, sparking a global pandemic.

An important milestone in pandemic preparedness is reached as FDA approves the first human vaccine for avian influenza H5N1.